|Articles|January 23, 2014
Analysis Shows Feasibility Studies Could be Conducted in Half the Time
Last September, inVentiv Clinical Trial Recruitment Solutions announced its strategic partnership with ViS Research to address the challenges of clinical trial site evaluation
Advertisement
Last September, inVentiv Clinical Trial Recruitment Solutions (iCTRS), announced its strategic partnership with ViS Research to address the challenges of clinical trial site evaluation. Four months later, the company has released analysis that could prove potential savings in the ViS platform for clinical trial feasibility studies. iCTRS took data from 100 feasibility studies conducted by inVentiv and analyzed the time required to perform each of the individual tasks involved in such studies. iCTRS then looked at how much time the application of ViS technology could save for each task. Cumulatively, the efficiencies offered by ViS cut the total feasibility study hours by 54% -- while delivering better quality.
Read the full release here .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
2
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
3
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
4